Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
384,509,293
-
Total 13F shares
-
204,615,301
-
Share change
-
-14,766,226
-
Total reported value
-
$14,470,118,235
-
Put/Call ratio
-
124%
-
Price per share
-
$70.75
-
Number of holders
-
526
-
Value change
-
-$1,021,479,918
-
Number of buys
-
338
-
Number of sells
-
205
Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q3 2020
As of 30 Sep 2020,
Moderna, Inc. - COMMON STOCK (MRNA) was held by
526 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
204,615,301 shares.
The largest 10 holders included
FMR LLC, Flagship Pioneering Inc., VANGUARD GROUP INC, BlackRock Inc., Theleme Partners LLP, BAILLIE GIFFORD & CO, STATE STREET CORP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and Bellevue Group AG.
This page lists
530
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.